Testosterone cypionate 100 MG/ML Injectable Solution — RxCUI 835829
RxNorm drug concept · Semantic clinical drug
RxCUI 835829
Semantic clinical drug · SCD
● Current RxNorm concept 18 FDA products
21 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI835829
Official nameTestosterone cypionate 100 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astestosterone cypionate 1000 MG per 10 ML Injectable Solution
FDA products mapped18
Package NDCs mapped21
Reported Medicaid activity (SDUD)215,601 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Testosterone Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Washing your hands is important, but it's not enough on its own. The gel on your shoulders and arms stays active on your skin for hours. If a child or woman touches that area, test...
- Why do I need to cover up after putting on the gel — can't I just wash my hands?
- Your prescriber will check your testosterone level with a morning blood draw — typically around 2 weeks and 4 weeks after starting or changing your dose. The goal is to keep your l...
- How will I know if the dose is right for me?
🕸️ Concept Web — How Testosterone cypionate 100 MG/ML Injectable Solu... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Testosterone cypionate 100 MG/ML Injectable Solution
RxCUI 835829 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Testosterone
10379IN -
Testosterone cypionate
835827PIN
-
Testosterone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Depo-testosterone
48877BN
-
Depo-testosterone
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Testosterone Injectable Solution
374050SCDF -
Testosterone cypionate Injectable Solution
2648605SCDFP -
Testosterone Injectable Product
1164841SCDG -
Testosterone cypionate Injectable Product
2663142SCDGP -
Testosterone Injectable Solution [Depo-testosterone]
363347SBDF -
Testosterone cypionate Injectable Solution [Depo-testosterone]
2657414SBDFP -
Depo-testosterone Injectable Product
1173115SBDG -
Injectable Solution
316949DF - +1 more in this family
-
Testosterone Injectable Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Testosterone cypionate 100 MG/ML
835828SCDC -
Testosterone cypionate 100 MG/ML Injectable Solution [Depo-testosterone]
835831SBD -
Testosterone cypionate 100 MG/ML [Depo-testosterone]
835830SBDC
-
Testosterone cypionate 100 MG/ML
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Testosterone cypionate 100 MG/ML
SCDC · 835828 -
Testosterone Injectable Solution
SCDF · 374050 -
Testosterone cypionate Injectable Solution
SCDFP · 2648605 -
Testosterone Injectable Product
SCDG · 1164841 -
Testosterone cypionate Injectable Product
SCDGP · 2663142
Brand-Name Concepts
-
Testosterone cypionate 100 MG/ML Injectable Solution [Depo-testosterone]
SBD · 835831 -
Testosterone cypionate 100 MG/ML [Depo-testosterone]
SBDC · 835830 -
Testosterone Injectable Solution [Depo-testosterone]
SBDF · 363347 -
Testosterone cypionate Injectable Solution [Depo-testosterone]
SBDFP · 2657414 -
Depo-testosterone Injectable Product
SBDG · 1173115 -
Depo-testosterone
BN · 48877
📦 FDA Products & Package NDCs
18 products · 21 package NDCs
21 package NDCs map to RxCUI 835829 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00009-0085-10 | 1 VIAL in 1 CARTON (0009-0085-10) / 10 mL in 1 VIAL | Depo-Testosterone | Pharmacia & Upjohn Company LLC | 2014-07-01 |
| 00009-0086-01 | 1 VIAL in 1 CARTON (0009-0086-01) / 1 mL in 1 VIAL | Depo-Testosterone | Pharmacia & Upjohn Company LLC | 2014-07-01 |
| 00009-0347-02 | 1 VIAL in 1 CARTON (0009-0347-02) / 10 mL in 1 VIAL | Depo-Testosterone | Pharmacia & Upjohn Company LLC | 1979-07-25 |
| 00009-0417-01 | 1 VIAL in 1 CARTON (0009-0417-01) / 1 mL in 1 VIAL | Depo-Testosterone | Pharmacia & Upjohn Company LLC | 1979-07-25 |
| 00009-0417-02 | 1 VIAL in 1 CARTON (0009-0417-02) / 10 mL in 1 VIAL | Depo-Testosterone | Pharmacia & Upjohn Company LLC | 1979-07-25 |
| 00409-6557-01 | 1 VIAL in 1 CARTON (0409-6557-01) / 10 mL in 1 VIAL | Testosterone Cypionate | Hospira, Inc. | 2016-08-01 |
| 00409-6562-01 | 1 VIAL in 1 CARTON (0409-6562-01) / 1 mL in 1 VIAL | Testosterone Cypionate | Hospira, Inc. | 2016-08-01 |
| 00409-6562-20 | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL | Testosterone Cypionate | Hospira, Inc. | 2016-08-01 |
| 55150-0276-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-276-01) / 10 mL in 1... | Testosterone Cypionate | Eugia US LLC | 2023-10-20 |
| 55150-0277-01 | 1 VIAL, GLASS in 1 CARTON (55150-277-01) / 1 mL in 1 VIAL,... | Testosterone Cypionate | Eugia US LLC | 2023-10-20 |
| 55150-0278-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1... | Testosterone Cypionate | Eugia US LLC | 2023-10-20 |
| 62756-0015-40 | 1 VIAL in 1 CARTON (62756-015-40) / 1 mL in 1 VIAL | Testosterone Cypionate | Sun Pharmaceutical Industries, Inc. | 2013-06-17 |
| 62756-0016-40 | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1... | Testosterone Cypionate | Sun Pharmaceutical Industries, Inc. | 2013-06-17 |
| 62756-0017-40 | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-017-40) / 10 mL in 1... | Testosterone Cypionate | Sun Pharmaceutical Industries, Inc. | 2013-06-17 |
| 69097-0536-37 | 10 mL in 1 VIAL, GLASS (69097-536-37) | TESTOSTERONE CYPIONATE | Cipla USA Inc. | 2023-09-15 |
| 69097-0537-31 | 1 mL in 1 VIAL, GLASS (69097-537-31) | TESTOSTERONE CYPIONATE | Cipla USA Inc. | 2023-09-15 |
| 69097-0537-37 | 10 mL in 1 VIAL, GLASS (69097-537-37) | TESTOSTERONE CYPIONATE | Cipla USA Inc. | 2023-09-15 |
| 70700-0288-22 | 1 VIAL in 1 CARTON (70700-288-22) / 10 mL in 1 VIAL | testosterone cypionate | Xiromed LLC | 2023-04-28 |
| 70700-0289-22 | 1 VIAL in 1 CARTON (70700-289-22) / 1 mL in 1 VIAL | testosterone cypionate | Xiromed LLC | 2023-04-28 |
| 70700-0290-22 | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL | testosterone cypionate | Xiromed LLC | 2023-04-28 |
| 76420-0425-10 | 1 VIAL in 1 CARTON (76420-425-10) / 10 mL in 1 VIAL | Depo-Testosterone | Asclemed USA, Inc. | 2025-08-08 |
Observed labelers:
Pharmacia & Upjohn Company LLC (5) ·
Cipla USA Inc. (3) ·
Eugia US LLC (3) ·
Hospira, Inc. (3) ·
Sun Pharmaceutical Industries, Inc. (3) ·
Xiromed LLC (3)
· +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1071 | Inj testosterone cypionate | 16 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.